PR023/#503  Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability

Bradley Corr; Samantha Thomas; Paulina Haight; Elizabeth Stock; Jessica Floyd; Lindsay Borden; Irina Tunnage; Angeles Alvarez Secord; Rebecca Arend; Amanda Jackson; Jason Wright; Gottfried Konecny; Tara Castellano; Emily Ko; Sarah Podwika; Floor Backes; Daniel Spinosa; Margaret Mullen; Christina Washington; Bhavana Pothuri; Carsen Smitherman; Alfonsus Harsono; Hanaa Khadraoui; Yukio Suzuki; Ritu Salani; Kristina Powell; Shalini Subbarao; Stephanie Gaillard

doi:10.1136/ijgc-2023-IGCS.65

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

PDF

Featured Posters: Poster Rounds with the Professors

AS04. Endometrial/Uterine corpus cancers

PR023/#503 Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability

Free

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password